Medical cannabis Syqe lays off 30% of its workforce

syqe-cannabis.jpg

This backing gave Syqe financial muscle and strategic reach—but also raises reputational and strategic risks, given tobacco’s fraught public perception in the health space. Imagine if McDonald’s bought into a regenerative kale farm. The cash infusion could scale production, but people would always wonder if the lettuce was being served with a side of fries. 

Read more

Half of all medical cannabis doses labeled incorrectly

medical-cannabis-colorado.png

Products were considered “accurately labeled” if they contained within 15% of the THC amount shown on the label—the same threshold the state uses. About 44% percent of flower products failed to meet that standard, with 54 of those products inflating their THC content and 23 containing more THC than the label indicated. Only four concentrate products were labeled inaccurately.

Read more

Portugal vies to become Europe’s medical cannabis hub but locals say beware of corruption

tilray-canada.jpg

Tilray Medical continues to be a global leader in the medical cannabis industry, offering a diverse portfolio of EU-GMP certified medicinal cannabis products. With operations extending over 20 countries, Tilray Medical is dedicated to supporting medical cannabis patient care worldwide through quality products accessible via healthcare practitioners. Its business in Portugal is a stepping stone to the rest of the EU. 

Read more